Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum days for obtaining report for Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test:

  • Results are typically reported within 5-7 business days after the test is conducted.
  • For urgent cases, a report may be obtained within 1-2 business days with additional charges.
  • Patient may contact the testing facility for specific information on report delivery times.

What are the prerequisites for the test Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test

  • Age: 11-13 weeks
  • Gestational Age: 14-21 weeks
  • Maternal Weight: >50 kg
  • Fasting: Not required
  • Sample: Serum

What are the measure values for the test Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test

  • Sensitivity: 85%
  • Specificity: 90%
  • Positive Predictive Value: 60%
  • Negative Predictive Value: 95%

What does this test Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test identify?

Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test

The Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test is a diagnostic test that identifies the presence of certain markers in the blood of pregnant women. This test is typically performed during the second trimester of pregnancy and is used to assess the risk of certain chromosomal abnormalities, such as Down syndrome.

The test measures the levels of various hormones and proteins in the mother's blood, including alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. Abnormal levels of these markers can indicate an increased risk of chromosomal abnormalities in the fetus.

The results of the Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test can help healthcare providers determine the need for further diagnostic testing, such as amniocentesis or chorionic villus sampling. It is important to note that this test does not provide a definitive diagnosis of chromosomal abnormalities, but rather helps to assess the risk.

Why is this test Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test taken?

Combined Screening (Intermediate)- AutoDELFIA (Astraia) Test is taken to assess the risk of certain chromosomal abnormalities in a fetus during pregnancy. This test combines a maternal blood test (measuring levels of certain proteins) with an ultrasound measurement of the nuchal translucency (thickness at the back of the baby's neck) to provide a more accurate assessment of the risk of conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

No FAQs available.

Customer Google Rating